![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 52, 49283-49288, December 28, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
AND RESISTANCE
TO EXONUCLEASE ACTION AT CYCLOPURINE DEOXYNUCLEOSIDE RESIDUES*
§,
,
,
,
**, and
From the
Imperial Cancer Research Fund, Clare Hall
Laboratories, South Mimms, Hertfordshire EN6 3LD, United Kingdom,
the ¶ Institute of Molecular and Cellular Biology, Osaka
University, 1-3 Yamada-oka, Suita, Osaka 565-0871, Japan, and the
Laboratoire des Lésions des Acides Nucléiques,
Service de Chimie Inorganique et Biologique and UMR 5046, Département de Recherche Fondamentale sur la Matière
Condensée, Commissariat á l'Energie Atomique, F-38054
Grenoble Cedex 9, France
Received for publication, August 13, 2001, and in revised form, October 1, 2001
| |
ABSTRACT |
|---|
|
|
|---|
Cyclopurine deoxynucleosides are common DNA
lesions generated by exposure to reactive oxygen species under hypoxic
conditions. The S and R diastereoisomers of
cyclodeoxyadenosine on DNA were investigated separately for their
ability to block 3' to 5' exonucleases. The mammalian DNA-editing
enzyme DNase III (TREX1) was blocked by both diastereoisomers, whereas
only the S diastereoisomer was highly efficient in
preventing digestion by the exonuclease function of T4 DNA polymerase.
Digestion in both cases was frequently blocked one residue before the
modified base. Oligodeoxyribonucleotides containing a
cyclodeoxyadenosine residue were further employed as templates for
synthesis by human DNA polymerase More than 30 different base lesions have been characterized in DNA
after exposure to reactive oxygen species (1, 2). Many of these are
ring-saturated or ring-condensed derivatives of pyrimidines. However,
oxidation of purines also occurs, in particular in association with
saturation or fragmentation of the imidazole ring of guanine. These
lesions are generally removed by specialized DNA glycosylases called
Nth and Fpg in Escherichia coli, and NTH1 and OGG1 in
human cells (3).
A structurally unusual form of lesion generated by hydroxyl
radicals is a cyclopurine deoxynucleoside
(cyPu).1 These are
increasingly recognized as significant, chemically stable lesions after
exposure of cells or DNA solutions to oxygen free radicals, with
cyclodeoxyadenosine being formed slightly more frequently than
cyclodeoxyguanosine (4, 5). A covalent bond is formed between the C-8
position of the purine and the C-5' residue of the
adjacent deoxyribose. Consequently, the base is attached to the DNA
backbone by two covalent bonds, one of which is the normal glycosyl
bond. After A cyPu can occur in two stereoisomeric forms, 5'R and
5'S (Fig. 1). Oxygen free radicals generate the
5'S and 5'R isomers in similar amounts in
double-stranded DNA, whereas the 5'R diastereoisomer is
predominant in single-stranded DNA (1, 2, 4). Until recently, synthesis
of oligodeoxyribonucleotides containing these adducts has been
technically difficult, in particular with regard to the R
diastereoisomer (9, 10). Because both cyPu lesions inhibit DNA
synthesis by replicative mammalian and microbial DNA polymerases (7),
and the S isomer of cyPu blocks gene expression (8), these
lesions would have a potentially cytotoxic effect.
Here, we have evaluated the susceptibility of oligonucleotides
containing this lesion in either of its diastereoisomeric forms to
several 3' exonucleases. The results suggest that stereospecific differences between R- and S-cyPu residues affect
the exonucleolytic activity. Oligonucleotides with either a single
R- or S-cyPu residue were further tested as
substrates for translesion synthesis by human polymerase Oligodeoxyribonucleotides Containing a Site-specific Purine
Cyclodeoxynucleoside Residue--
Oligodeoxyribonucleotides with
either a (5'R)-5',8-cyclo-2'-deoxyadenosine
(5'R-cyclo-dA) or
(5'S)-5',8-cyclo-2'-deoxyadenosine residue
(5'S-cyclo-dA) were prepared using modified phosphoramidite chemistry as described (9, 10). The lesions were
incorporated into the sequence
5'-CACTTCGGXTCGTGACTGATCT-3', where X is
5'R-cyclo-dA or 5'S-cyclo-dA. The
oligonucleotides were 5'-phosphorylated using [ Nuclease Assays--
Mammalian DNase III (TREX1), which is a
major nuclear DNA-specific 3' exonuclease with properties of an editing
factor, was purified from cell nuclei as described (14). T4 DNA
polymerase, which has a 3' exonucleolytic function, was obtained from
New England Biolabs.
For 3' exonucleolytic digestion, 5'-32P end-labeled
oligonucleotides containing either a 5'R-cyclo-dA or
5'S-cyclo-dA residue or control oligonucleotides without a
lesion were incubated with different amounts of exonucleases as
indicated in the figure legends. T4 DNA polymerase was assayed in
10-µl reaction mixtures containing 50 mM NaCl, 10 mM Tris-HCl (pH 7.9), 10 mM MgCl2,
and 1 mM dithiothreitol at 37 °C for 30 min. For
mammalian DNase III assays, 10-µl reaction mixtures containing 50 mM Tris-HCl (pH 7.5), 4 mM MgCl2, 1 mM dithiothreitol, and 100 µl/ml bovine serum albumin
were used, and incubations were at 37 °C for 30 min. Reactions were
terminated by the addition of 8 µl of stop solution containing 95%
formamide, 20 mM EDTA, 0.025% bromphenol blue, and 0.025%
xylene cyanol. Oligonucleotide fragments were separated by
electrophoresis on a denaturing 16% polyacrylamide gel, dried, and
exposed to x-ray film (Kodak Bio-Max) or a PhosphorImager screen
(Molecular Dynamics).
Translesion Synthesis Assays--
The 5'-32P-labeled
primer-template DNA was prepared by mixing a 13-mer (Fig.
3A) or 14-mer (Fig. 4, C and D) primer
labeled at its 5' end with a 22-mer oligonucleotide containing either a
5'R-cyclo-dA or a 5'S-cyclo-dA residue at a molar
ratio of 1:1. Reaction mixtures of 5 µl contained 40 mM
Tris-HCl (pH 8.0), 1 mM MgCl2, the four dNTPs
at 100 µM each, 10 mM dithiothreitol, 250 µl/ml bovine serum albumin, 60 mM KCl, 2.5% glycerol,
and 40 nM of the 5'-32P-labeled primer-template
DNA were incubated at 37 °C for 15 min. Reactions were terminated by
the addition of 8 µl of stop solution. Products were separated by
electrophoresis on a denaturing 16% polyacrylamide gel, dried, and
exposed as described above.
Structure of cyPu--
A model indicating how the R and
S diastereoisomers arise from 8,5'-cyclodeoxyadenosine is
shown in Fig. 1. Molecular mechanics calculations predict that the deoxyribose moiety is anomalously puckered, a distortion required to form the C(5')-C (8) bond (15). The
attendant changes in DNA conformation would greatly weaken base pairing
with a complementary residue in the double helix (15). The distorted
structure of the lesion is consistent with its ability to block DNA
replication and transcription (7, 8).
Exonucleolytic Activity on cyPu Residues--
Distinct structural
distortions of DNA caused by the two diastereoisomers of cyPu residues
could be detected in principle by the relative sensitivities of the
lesions to exonucleolytic digestion. To investigate this point,
oligonucleotides containing a site-specific cyPu residue were incubated
with T4 DNA polymerase, which functions as a processive 3' to 5'
exonuclease in the absence of deoxynucleoside triphosphates. This
enzyme has been used previously to detect bulky DNA lesions such as UV
photoproducts, psoralen interstrand cross-links, and cisplatin adducts.
Exonucleolytic activity is typically blocked 1-3 nucleotides from the
site of bulky DNA damage (16, 17). Fig.
2B shows that the
exonucleolytic activity of T4 DNA polymerase is strongly inhibited one
nucleotide from 5'S-cyclo-dA as indicated by the
accumulation of a 10-mer even after attempted digestion at high enzyme
concentrations. In contrast, the oligonucleotide containing
5'R-cyclo-dA could be cleaved to mononucleotides, although
the lesion functioned as a pause site that partly blocked exonuclease
activity, as seen at lower enzyme concentrations (Fig. 2B,
lanes 6-10). These results demonstrate that stereospecific
differences between the 5'R- and 5'S-cyclo-dA
residues differently affect the exonucleolytic action of T4 DNA
polymerase. It is interesting that the 5'S diastereoisomer was a much stronger block to exonucleolytic degradation by T4 DNA
polymerase than the 5'R analogue, although the R
form was a better NER substrate than the S form (7).
The mammalian nuclear 3' to 5' exonuclease DNase III/TREX1 can remove a
mismatched nucleotide residue from the 3' terminus of double-stranded
DNA and effectively digests nondamaged single-stranded DNA (14, 18).
This enzyme has sequence homology with the proofreading DnaQ protein of
the E. coli pol III holoenzyme as well as with the 3'
exonuclease domain of eukaryotic DNA polymerase
In additional experiments, oligonucleotides with a cyPu residue were
incubated with the 3' to 5' exonuclease activity of E. coli
exonuclease III, snake venom phosphodiesterase, or nuclease P1 in
similar assays. A small region adjacent to the cyPu lesion was
apparently protected from digestion by these enzymes, indicating that
cyPu residues in monomeric form could not be released (data not shown).
However, we did not detect stereospecific differences between digestion
of 5'R- and 5'S-cyclo-dA residues with these enzymes.
Translesion Synthesis on cyPu Residues--
To examine whether pol
To examine the nucleotide preference for incorporation opposite a
lesion by pol The cyPu lesions generated by reactive oxygen species potentially
have a cytotoxic effect by inhibiting DNA replication and transcription. Such lesions in DNA can be removed by the nucleotide excision-repair (NER) machinery, albeit inefficiently, but not by the
base excision-repair machinery and not by a direct reversal reaction in
human cells (7, 8).
In this study, we have found that stereospecific differences between
the 5'R- and 5'S-cyclo-dA residues affect the
relative resistance to exonucleolytic activity (Fig. 2) and give rise
to different efficiencies of translesion synthesis by pol
(pol
). pol
could catalyze
translesion synthesis on the R diastereoisomer of
cyclodeoxyadenosine. On the S diastereoisomer, pol
could catalyze the incorporation of one nucleotide opposite the lesion but could not continue elongation. Although pol
preferentially incorporated dAMP opposite the R diastereoisomer,
elongation continued only when dTMP was incorporated, suggesting bypass
of this lesion by pol
with reasonable fidelity. With the
S diastereoisomer, pol
mainly incorporated dAMP or dTMP
opposite the lesion but could not elongate even after incorporating a
correct nucleotide. These data suggest that the S
diastereoisomer may be a more cytotoxic DNA lesion than the
R diastereoisomer.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-irradiation of a neutral DNA solution under
N2O, 8,5'-cyclo-2'-deoxyadenosine was generated at a
10-fold lower yield that the major lesions 8-oxo-7,8-dihydroguanine or
thymine glycol (6). The cyPu lesions have recently been shown to be
corrected by nucleotide excision repair (NER) rather than by a process
related to base excision repair or direct damage reversal (7, 8). Thus,
the main mode of repair for this form of oxidative DNA damage is
different from that of the great majority of oxidative base lesions.
(pol
).
Human pol
is the product of the XPV gene, which is
mutated in a cancer-prone genetic disorder, xeroderma pigmentosum
variant (11, 12). The enzyme can catalyze efficient and accurate
translesion synthesis opposite lesions such as a cyclobutane thymine
dimer generated by UV irradiation (11, 12) and 8-oxo-7,8-dihydroguanine
generated by hydroxyl radicals (13). We find that stereospecific
differences between R- and S-cyPu residues also
affect translesion synthesis, with the S-cyPu much less
efficiently bypassed. As reported previously (7), the S
diastereoisomer is removed by NER even less efficiently than the
R isomer. The present data provide additional reasons why
the S diastereoisomer might be more of a challenge to cell survival than the R diastereoisomer in vivo.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-32P]ATP (Amersham Biosciences, Inc.) and T4
polynucleotide kinase (New England Biolabs) and then purified on a
denaturing 16% polyacrylamide gel. Double-stranded DNA substrates for
exonucleases were prepared by annealing with a complementary strand of
sequence 5'-AGATCAGTCACGATCCGAAGTG-3'.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (19K):
[in a new window]
Fig. 1.
The 5'R
and 5'S diastereoisomers of
5',8-cyclodeoxyadenosine. The diagram at the top
indicates the proximity of the H-8 of adenine to two hydrogens
on the C-5' of deoxyribose. In DNA, oxygen free radicals can promote
loss of the hydrogen labeled pro-R, leading to the
5'R diastereoisomer at the lower left or loss of
the hydrogen labeled pro-S, leading to the 5'S
diastereoisomer at the lower right. Unusual sugar puckering
(not shown here) arises as a consequence of the close proximity of the
8 and 5' positions in the cyclized adduct (15).

View larger version (41K):
[in a new window]
Fig. 2.
Partial resistance to exonucleases.
A, schematic drawing of 22-mer oligonucleotide containing a
cyPu residue. The positions of partly or fully blocked digestion by 3'
exonuclease activity are indicated. B, action of the
exonuclease function of T4 DNA polymerase on an oligonucleotide
containing a purine cyclodeoxynucleoside. Control oligonucleotide
(lanes 1-5), 5'R-cyclodeoxyadenosine-containing
oligonucleotide (lanes 6-10), and
5'S-cyclodeoxyadenosine-containing oligonucleotide
(lanes 11-15) were digested with increasing amounts of T4
DNA polymerase (0.3, 0.75, 1.5, and 3 units) in the absence of
deoxynucleoside triphosphates at 37 °C for 30 min. C,
action of the exonuclease function of mammalian DNase III on an
oligonucleotide containing a purine cyclodeoxynucleoside. A control
oligonucleotide (lanes 1-5), a
5'R-cyclodeoxyadenosine-containing oligonucleotide
(lanes 6-10), and a
5'S-cyclodeoxyadenosine-containing oligonucleotide
(lanes 11-15) were digested with increasing amounts of
DNase III (25, 50, 100, and 150 fmol) at 37 °C for 30 min.
, and has
biochemical properties consistent with a role in DNA editing. Fig.
2C shows that the exonucleolytic activity of DNase III was strongly blocked by both 5'R- and 5'S-cyclo-dA
(lanes 6-15), whereas oligonucleotides without a lesion
were completely digested (lanes 1-5). The strong block to
DNase III digestion by a 5'R-cyclo-dA residue was in
contrast to the results obtained with T4 DNA polymerase (Fig.
2B, lanes 6-10). The predominant digestion
product of 5'R-cyclo-dA by DNase III was a 9-mer, whereas
that of 5'S-cyclo-dA was a 10-mer at the same enzyme
concentration. These observations also indicated that stereospecific
differences between 5'R- and 5'S-cyclo-dA residues differently affect the exonucleolytic action of DNase III.
had translesion synthesis activity at cyPu residues, a 22-mer
oligonucleotide containing a single lesion was employed as template and
annealed to a 5'-32P-labeled 13-mer oligonucleotide (Fig.
3A). The latter served as a
primer and was positioned so that the first nucleotide was incorporated
opposite a single 5'R- or 5'S-cyclo-dA residue.
T7 DNA polymerase (T7 pol), and pol
could synthesize DNA products of up to 22 nucleotides in length on the control template (Fig. 3B, lanes 1-6). Under these conditions,
synthesis increased linearly up to 1.2 fmol of pol
, suggesting that
the enzyme catalyzed synthesis without recycling. As reported
previously (11, 12), pol
is able to bypass UV-induced cyclobutane
pyrimidine dimers, similar to related translesion polymerases such as
E. coli pol V (umuD'2·C complex) (19,
20) and yeast pol
(21). When the template DNA contained a
5'R-cyclo-dA residue, pol
could catalyze some
translesion synthesis at higher enzyme concentrations (Fig.
3B, lanes 8-12). On the other hand, using
template DNA with a 5'S-cyclo-dA residue, pol
incorporated one nucleotide opposite the single lesion in reactions
with a high enzyme concentration, but bypass products were hardly
detected (Fig. 3B, lanes 14-18). T7 pol could
incorporate one nucleotide opposite either 5'R- or 5'S-cyclo-dA residues (Fig. 3B, lanes
7 and 13) as reported (7). From these results, we
conclude that human pol
has the ability to bypass a
5'R-cyclo-dA residue with only weak activity on the 5'S
diastereoisomer.

View larger version (62K):
[in a new window]
Fig. 3.
Translesion synthesis by human pol
. A, DNA template for the lesion
bypass DNA polymerase assay. A 13-mer primer was 5'-labeled with
32P and annealed with the 22-mer oligonucleotide containing
the lesion. The position of control-dA, 5'R-cyclo-dA, or
5'S-cyclo-dA in the DNA is indicated in bold.
B, Lanes 1, 7, and 13 contained 0.1 units of T7 polymerase. Control-dA (lanes
1-6), 5'R-cyclo-dA (lanes 7-12), and
5'S-cyclo-dA (lanes 13-18) in the DNA template
were incubated with increasing amounts of pol
(0, 0.1, 0.2, 0.4, and 1.2 fmol) at 37 °C for 30 min.
, polymerization reactions were performed in the
presence of only a single deoxynucleotide (Fig.
4A). Pol
replicates
undamaged DNA with low fidelity (22). As reported previously (11), pol
stops synthesis after incorporating an incorrect nucleotide even on
undamaged templates. This activity was observed on our control template
(Fig. 4B, lanes 4-7). When A was the template
nucleotide, dTTP was incorporated more than other nucleotides. On a
template containing a 5'R-cyclo-dA residue, pol
instead
preferred to incorporate dATP but could also incorporate the other
three nucleotides to some extent (Fig. 4B, lanes
11-14). On the other hand, using a template containing a
5'S-cyclo-dA residue, pol
preferentially incorporated
either dAMP or dTMP opposite the lesion (Fig. 4B,
lanes 18-21). For lesion bypass, nucleotides must be
incorporated beyond the lesion after the initial incorporation (in this
case, "incorrect" dAMP or "correct" dTMP) opposite the lesion.
To test this model, we designed two sets of 14-mer primers that
had two different sequences at their 3' ends, to determine which
sequence allowed pol
to elongate past the lesion. When the 14-mer
primer had the sequence A opposite a control dA, 5'R-, or
5'S-cyclo-dA, pol
could not continue synthesis of DNA
chains from a primer terminus (Fig. 4C, lanes 2-4). These data indicate that pol
stopped DNA synthesis
after incorporating one dAMP opposite the lesion. On a primer
containing the sequence T (the correct nucleotide), pol
could
elongate DNA chains on the control-dA or 5'R-cyclo-dA but
only inefficiently on the 5'S-cyclo-dA (Fig.
4D).

View larger version (56K):
[in a new window]
Fig. 4.
Nucleotide selectivity of pol
incorporation opposite a cyPu lesion.
A, schematic drawing of a 22-mer oligonucleotide with the
lesion, annealed to a 32P-labeled primer. B, Pol
was incubated with template DNA in the presence of all four dNTPs
(lanes 3, 10, and 17), with one of the
indicated dNTPs (lanes 4-7, 11-14, and
18-21), or in the absence of dNTPs (lanes 2,
9, and 16). C and D,
ability of pol
(1 fmol) to elongate DNA chains past the cyPu
lesion. 32P-labeled 14-mer primer contained a terminal A
(panel C) or T (panel D) at the 3' end and was
annealed to a 22-mer oligonucleotide with control-dA (lane
2), 5'R-cyclo-dA (lane 3), or
5'S-cyclo-dA (lane 4) or without 22-mer
oligonucleotide (lane 1).
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
(Figs. 3
and 4). We noted differences previously in the efficiency of the human
NER pathway to remove the 5'R- and 5'S-cyclo-dA
lesions from double-stranded DNA. The S diastereoisomer was
less efficiently removed by NER than the R isomer in
human cells. These and current data are summarized in Table
I. Oxygen free radicals generate the
5'S and 5'R isomer in similar amounts in duplex
DNA (1, 2, 4). Because the S diastereoisomer is less
efficiently repaired and, as shown here, is also less efficiently
bypassed by pol
, the S diastereoisomer is likely to be a
more highly cytotoxic DNA lesion than the R
diastereoisomer in vivo.
Summary of NER efficiency, translesion synthesis by pol
, and
resistance to exonuclease action at cyPu residues
To bypass the 5'S diastereoisomer, human cells might need
another polymerase or co-factor in addition to pol
. Such
error-prone bypass reactions could result in mutations caused by cyPu
residues. By comparison, it has been reported that yeast pol
stops
DNA synthesis after incorporating one dCMP opposite an AAF-G and either dGMP or dAMP opposite an apurinic/apyrimidinic site (23) and that yeast
pol
can then extend DNA synthesis past the AP site. Another group
(24) reported that human pol
(hRad30B) incorporated one nucleotide
opposite a (6-4) T-T photoproduct but that the enzyme was unable to
extend DNA synthesis past the lesion. Yeast pol
could extend this
product. In E. coli, RecA protein efficiently stimulates
lesion bypass by pol V (23).
Because cyPu lesions seem to be removed only by the
nucleotide excision repair system in vivo, NER-defective
xeroderma pigmentosum patients may accumulate this stable chemical
lesion in the DNA of nonregenerating cells over long periods of time,
because of endogenous oxidative damage. Lesion accumulation could also
be fostered in dividing cells by translesion polymerases such as pol
and pol
. Because cyPu lesions potentially could inhibit both DNA replication and transcription (8), the lesions would be a
challenge to maintenance of cell viability. Such lesion accumulation could be a cause of the slow but progressive neural degeneration observed in xeroderma pigmentosum patients who are protected from sun
exposure (7, 8).
Randerath and co-workers used a sensitive 32P-postlabeling
method to detect small amounts of indigenous altered nucleotides, called I compounds, in enzymatic hydrolysates of DNA from mammalian cells (for review, see Ref. 25). The chemical nature of the various I
compounds, each of which is typically present at a level of 5-200
residues/mammalian genome, have remained unknown. However, several
major I compounds that were particularly abundant after cellular
oxidative stress have been identified recently, as dinucleotides containing a 8,5'-cyclo-2'-deoxyadenosine moiety (26). These finding
provide strong evidence that cyPu residues are highly relevant
oxidative lesions in mammalian DNA. They are presumably generated
continuously by oxidative stress and then are slowly removed by
nucleotide excision repair, so that a steady state level of the lesion
is observed in vivo.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Drs. John Essigmann, Kaushik Mitra, and Paul Henderson (Massachusetts Institute of Technology) for discussions and Kaushik Mitra for drawing Fig. 1.
| |
FOOTNOTES |
|---|
* This work was supported by the Imperial Cancer Research Fund and by grants from the French Atomic Energy Commission and the Comité de Radioprotection d'Electricité de France (to J. C.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ Recipient of a postdoctoral fellowship from the Japan Society for the Promotion of Science. Present address: Institute of Molecular and Cellular Biology, Osaka University, 1-3 Yamada-oka, Suita, Osaka 565-0871, Japan.
** To whom correspondence should be addressed: University of Pittsburgh Cancer Institute, S867 Scaife Hall, Box 100, Pittsburgh, PA 15261. Tel.: 412-648-9248; Fax: 412-383-9822; E-mail: rdwood@pitt.edu.
Published, JBC Papers in Press, October 24, 2001, DOI 10.1074/jbc.M107779200
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
cyPu, cyclopurine
2'-deoxynucleoside;
5'R-cyclo-dA, (5'R)-5',8-cyclo-2'-deoxyadenosine;
5'S-cyclo-dA, (5'S)-5',8-cyclo-2'-deoxyadenosine;
T7 pol, T7 DNA polymerase;
pol
, DNA polymerase
;
NER, nucleotide
excision repair.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Dizdaroglu, M. (1992) Int. J. Radiat. Biol. 61, 175-183 |
| 2. | Cadet, J., Delatour, T., Douki, T., Gasparutto, D., Pouget, J. P., Ravanat, J. L., and Sauvaigo, S. (1999) Mutat. Res. 424, 9-21 |
| 3. | Lindahl, T., and Wood, R. D. (1999) Science 286, 1897-1905 |
| 4. | Dizdaroglu, M., Dirksen, M. L., Jiang, H. X., and Robbins, J. H. (1987) Biochem. J. 241, 929-932 |
| 5. | Schroder, E., Budzinski, E. E., Wallace, J. C., Zimbrick, J. D., and Box, H. C. (1995) Int. J. Radiat. Biol. 68, 509-523 |
| 6. | Dizdaroglu, M., Jaruga, P., and Rodriguez, H. (2001) Free Radic. Biol. Med. 30, 774-784 |
| 7. | Kuraoka, I., Bender, C., Romieu, A., Cadet, J., Wood, R. D., and Lindahl, T. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 3832-3837 |
| 8. | Brooks, P. J., Wise, D. S., Berry, D. A., Kosmoski, J. V., Smerdon, M. J., Somers, R. L., Mackie, H., Spoonde, A. Y., Ackerman, E. J., Coleman, K., Tarone, R. E., and Robbins, J. H. (2000) J. Biol. Chem. 275, 22355-22362 |
| 9. | Romieu, A., Gasparutto, D., Molko, D., and Cadet, J. (1998) J. Org. Chem. 63, 5245-5249 |
| 10. | Romieu, A., Gasparutto, D., and Cadet, J. (1999) Chem. Res. Toxicol. 12, 412-421 |
| 11. | Masutani, C., Kusumoto, R., Yamada, A., Dohmae, N., Yokoi, M., Yuasa, M., Araki, M., Iwai, S., Takio, K., and Hanaoka, F. (1999) Nature 399, 700-704 |
| 12. | Johnson, R. E., Kondratick, C. M., Prakash, S., and Prakash, L. (1999) Science 285, 263-265 |
| 13. | Haracska, L., Yu, S. L., Johnson, R. E., Prakash, L., and Prakash, S. (2000) Nat. Genet. 25, 458-461 |
| 14. | Höss, M., Robins, P., Naven, T. J., Pappin, D. J., Sgouros, J., and Lindahl, T. (1999) EMBO J. 18, 3868-3875 |
| 15. | Miaskiewicz, K., Miller, J. H., and Fuciarelli, A. F. (1995) Nucleic Acids Res. 23, 515-521 |
| 16. | Moggs, J. G., Yarema, K. J., Essigmann, J. M., and Wood, R. D. (1996) J. Biol. Chem. 271, 7177-7186 |
| 17. | Rampino, N. J., and Bohr, V. A. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 10977-10981 |
| 18. | Mazur, D. J., and Perrino, F. W. (2001) J. Biol. Chem. 276, 17022-17029 |
| 19. | Tang, M., Shen, X., Frank, E. G., O'Donnell, M., Woodgate, R., and Goodman, M. F. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 8919-8924 |
| 20. | Reuven, N. B., Arad, G., Maor-Shoshani, A., and Livneh, Z. (1999) J. Biol. Chem. 274, 31763-31766 |
| 21. | Johnson, R. E., Prakash, S., and Prakash, L. (1999) Science 283, 1001-1004 |
| 22. | Matsuda, T., Bebenek, K., Masutani, C., Hanaoka, F., and Kunkel, T. A. (2000) Nature 404, 1011-1013 |
| 23. | Tang, J. Y., Hwang, B. J., Ford, J. M., Hanawalt, P. C., and Chu, G. (2000) Mol Cell 5, 737-744 |
| 24. | Johnson, R. E., Washington, M. T., Haracska, L., Prakash, S., and Prakash, L. (2000) Nature 406, 1015-1019 |
| 25. | Randerath, K., Randerath, E., Zhou, G. D., and Li, D. (1999) Mutat. Res. 424, 183-194 |
| 26. | Randerath, K., Zhou, G. D., Somers, R. L., Robbins, J. H., and Brooks, P. J. (2001) J. Biol. Chem. 276, 36051-36057 |
This article has been cited by other articles:
![]() |
R. R. Laposa, E. J. Huang, and J. E. Cleaver Increased apoptosis, p53 up-regulation, and cerebellar neuronal degeneration in repair-deficient Cockayne syndrome mice PNAS, January 23, 2007; 104(4): 1389 - 1394. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Jaruga, J. Theruvathu, M. Dizdaroglu, and P. J. Brooks Complete release of (5'S)-8,5'-cyclo-2'-deoxyadenosine from dinucleotides, oligodeoxynucleotides and DNA, and direct comparison of its levels in cellular DNA with other oxidatively induced DNA lesions Nucleic Acids Res., June 23, 2004; 32(11): e87 - e87. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. G. Minko, M. T. Washington, M. Kanuri, L. Prakash, S. Prakash, and R. S. Lloyd Translesion Synthesis past Acrolein-derived DNA Adduct, gamma -Hydroxypropanodeoxyguanosine, by Yeast and Human DNA Polymerase eta J. Biol. Chem., January 3, 2003; 278(2): 784 - 790. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Kokoska, K. Bebenek, F. Boudsocq, R. Woodgate, and T. A. Kunkel Low Fidelity DNA Synthesis by a Y Family DNA Polymerase Due to Misalignment in the Active Site J. Biol. Chem., May 24, 2002; 277(22): 19633 - 19638. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |